MARZO, TIZIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.397
EU - Europa 2.426
AS - Asia 1.273
SA - Sud America 255
AF - Africa 31
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.405
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.364
RU - Federazione Russa 901
PL - Polonia 520
SG - Singapore 346
IT - Italia 336
CN - Cina 265
HK - Hong Kong 259
IE - Irlanda 231
BR - Brasile 210
SE - Svezia 126
KR - Corea 116
VN - Vietnam 103
FI - Finlandia 74
DE - Germania 72
GB - Regno Unito 63
IN - India 50
JO - Giordania 42
ID - Indonesia 30
CA - Canada 19
AR - Argentina 18
AU - Australia 18
ES - Italia 18
FR - Francia 18
UA - Ucraina 18
BE - Belgio 13
CH - Svizzera 11
TR - Turchia 11
JP - Giappone 10
MX - Messico 10
ZA - Sudafrica 10
CI - Costa d'Avorio 9
BD - Bangladesh 8
IQ - Iraq 8
CO - Colombia 7
EC - Ecuador 7
NL - Olanda 7
BG - Bulgaria 5
MA - Marocco 5
PK - Pakistan 4
UZ - Uzbekistan 4
XK - ???statistics.table.value.countryCode.XK??? 4
AT - Austria 3
CL - Cile 3
PE - Perù 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
IL - Israele 2
KZ - Kazakistan 2
NI - Nicaragua 2
PH - Filippine 2
PY - Paraguay 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BB - Barbados 1
BW - Botswana 1
CR - Costa Rica 1
DK - Danimarca 1
EU - Europa 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
NP - Nepal 1
OM - Oman 1
QA - Qatar 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
TG - Togo 1
Totale 8.405
Salva come PNG Salva come JPEG
Città #
Santa Clara 989
Warsaw 519
Fairfield 505
Ashburn 408
Chandler 250
Woodbridge 245
Dublin 231
Singapore 224
Seattle 212
Hong Kong 210
Houston 188
Cambridge 182
Wilmington 156
Ann Arbor 120
Seoul 116
Beijing 110
Florence 104
Lawrence 89
Altamura 87
Princeton 68
New York 62
Moscow 52
Buffalo 50
Boston 46
Los Angeles 44
Munich 40
Clifton 37
Ho Chi Minh City 35
Turku 32
Mumbai 31
Medford 24
Shanghai 24
Dallas 23
Hanoi 19
Jakarta 19
Melbourne 17
The Dalles 17
Boardman 16
Hefei 15
Helsinki 15
London 15
San Diego 15
Brussels 13
Barcelona 11
Redondo Beach 11
São Paulo 11
Bern 10
Chicago 10
Kent 10
Toronto 10
Abidjan 9
Dong Ket 9
Paris 9
Rio de Janeiro 9
Serra 8
Falls Church 7
Jacksonville 7
Norwalk 7
Tokyo 7
Yubileyny 7
Brooklyn 6
Rome 6
Baghdad 5
Denver 5
Frankfurt am Main 5
Lappeenranta 5
Lấp Vò 5
Manchester 5
New Delhi 5
Orem 5
Pisa 5
Porto Alegre 5
San Francisco 5
Sofia 5
Stockholm 5
Atlanta 4
Belo Horizonte 4
Cagliari 4
Council Bluffs 4
Curitiba 4
Da Nang 4
Fiesole 4
Hillsboro 4
Istanbul 4
Johannesburg 4
Messina 4
Montreal 4
Phoenix 4
Poppi 4
São Bernardo do Campo 4
Tashkent 4
Tianjin 4
Valeggio Sul Mincio 4
Washington 4
Andover 3
Biên Hòa 3
Campinas 3
Casablanca 3
Castelliri 3
Chennai 3
Totale 5.997
Salva come PNG Salva come JPEG
Nome #
FROM CONVENTIONAL TO NOVEL Pt-BASED ANTINEOPLASTIC AGENTS: MECHANISTIC ASPECTS AND BIOLOGICAL EFFECTS 332
A first-in-class and a fished out anticancer platinum compound:: Cis -[PtCl2(NH3)2] and cis -[PtI2(NH3)2] compared for their reactivity towards DNA model systems 300
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 296
A Fluorescent Silver(I) Carbene Complex with Anticancer Properties: Synthesis, Characterization, and Biological Studies 291
Iridium(I) Compounds as Prospective Anticancer Agents: Solution Chemistry, Antiproliferative Profiles and Protein Interactions for a Series of Iridium(I) N-Heterocyclic Carbene Complexes 280
Reactions of model proteins with aurothiomalate, a clinically established gold(I) drug: The comparison with auranofin 232
Auranofin, Et3PAuCl, and Et3PAuI Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study 226
PtI2(DACH), the iodido analogue of oxaliplatin as a candidate for colorectal cancer treatment: chemical and biological features 216
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 212
Auranofin and its Analogues Show Potent Antimicrobial Activity Covering Multiresistant Pathogens: Structure-Activity Relationships 198
The combined activation of K Ca 3.1 and inhibition of K v 11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells 198
Elucidating the reactivity of Pt(II) complexes with (O,S) bidentate ligands towards DNA model systems 175
Cisplatin and its dibromido analogue: a comparison of chemical and biological profiles 175
Gold(III) complexes with hydroxyquinoline, aminoquinoline and quinoline ligands: Synthesis, cytotoxicity, DNA and protein binding studies 171
Diruthenium Diacetate-Catalyzed Aerobic Oxidation of Hydroxylamines and Improved Chemoselectivity by Immobilization to Lysozyme 171
Chlorido and bromido oxaliplatin analogues as potential agents for CRC treatment: Solution behavior, protein binding and cytotoxicity evaluation 170
Arsenoplatin-1 Is a Dual Pharmacophore Anticancer Agent 169
The leading established metal-based drugs: a revisitation of their relevant physico-chemical data 169
A case of extensive protein platination: The reaction of lysozyme with a Pt(ii)-terpyridine complex 161
Reaction with proteins of a five-coordinate platinum(II) compound 160
ESI-MS studies of the reactions of novel platinum(II) complexes containing O,O'-chelated acetylacetonate and sulfur ligands with selected model proteins 158
Synthesis, characterization and DNA interactions of [Pt3(TPymT)Cl3], the trinuclear platinum(II) complex of the TPymT ligand 158
Cytotoxic activity and protein binding through an unusual oxidative mechanism by an iridium(I)–NHC complex 157
Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin 157
Interaction of anticancer Ru(III) complexes with single stranded and duplex DNA model systems 156
Interactions of the organogold(III) compound Aubipyc with the copper chaperone Atox1: A joint mass spectrometry and circular dichroism investigation 155
Oxaliplatin vs. cisplatin: Competition experiments on their binding to lysozyme 153
Drug repositioning: auranofin as a prospective antimicrobial agent for the treatment of severe staphylococcal infections 145
Protein Metalation by Anticancer Metallodrugs: A Joint ESI MS and XRD Investigative Strategy 145
cis-Pt I2(NH3)2: a reappraisal 140
Interaction of a gold(i) dicarbene anticancer drug with human telomeric DNA G-quadruplex: solution and computationally aided X-ray diffraction analysis 134
The cisplatin/serum albumin system: A reappraisal 133
Synthesis and Mode of Action Studies on Iridium(I)–NHC Anticancer Drug Candidates 131
Interplay of crystallography, Raman microspectroscopy and electrospray mass spectrometry for studying the reaction between ruthenium complexes and proteins 127
New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules 127
Reactions of Cytotoxic Metallodrugs with Lysozyme in pure DMSO explored through UV-Vis Absorption Spectroscopy and ESI MS 126
Interactions between Anticancertrans-Platinum Compounds and Proteins: Crystal Structures and ESI-MS Spectra of Two Protein Adducts oftrans-(Dimethylamino)(methylamino)dichloridoplatinum(II) 116
Ruthenium(II) 1,4,7-trithiacyclononane complexes of curcumin and bisdemethoxycurcumin: Synthesis, characterization, and biological activity 114
Platinum(II) Complexes with O,S Bidentate Ligands: Biophysical Characterization, Antiproliferative Activity, and Crystallographic Evidence of Protein Binding 111
Peculiar Features in the Crystal Structure of the Adduct Formed betweencis-PtI2(NH3)2and Hen Egg White Lysozyme 108
The first step of arsenoplatin-1 aggregation in solution unveiled by solving the crystal structure of its protein adduct 107
Mechanistic studies on cytotoxic gold compounds 106
The X-ray structure of the complex formed in the reaction between oxaliplatin and lysozyme 103
On the Different Mode of Action of Au(I)/Ag(I)-NHC Bis-Anthracenyl Complexes Towards Selected Target Biomolecules 101
Mechanistic Insights Into the Anticancer Properties of the Auranofin Analog Au(PEt3)I: A Theoretical and Experimental Study 101
Synthesis, DNA binding studies, and antiproliferative activity of novel Pt(II)-complexes with an L-alanyl-based ligand 101
Description of a Non-Canonical AsPt Blue Species Originating from the Aerobic Oxidation of AP-1 in Aqueous Solution 100
Interactions of carboplatin and oxaliplatin with proteins: Insights from X-ray structures and mass spectrometry studies of their ribonuclease A adducts 100
Reactions of Arsenoplatin-1 with Protein Targets: A Combined Experimental and Theoretical Study 99
Reactions of cisplatin and cis-[PtI2(NH3)2] with molecular models of relevant protein sidechains: A comparative analysis 96
A Role for Metal-Based Drugs in Fighting COVID-19 Infection? The Case of Auranofin 95
In vitro anti-sars-cov-2 activity of selected metal compounds and potential molecular basis for their actions based on computational study 91
Unusual Structural Features in the Lysozyme Derivative of the Tetrakis(acetato)chloridodiruthenium(II,III) Complex 90
Reactions of a tetranuclear Pt-thiosemicarbazone complex with model proteins 86
null 47
null 31
The impact of albumin conjugation on the cytotoxic properties of cisplatin, oxaliplatin and auranofin in cancer cells 5
New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules 4
Reactions of Arsenoplatin-1 with Protein Targets: A Combined Experimental and Theoretical Study (2022) Inorganic Chemistry 4
null 2
Totale 8.522
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.361
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021396 0 0 0 0 0 44 30 36 90 116 48 32
2021/2022403 5 25 32 13 28 16 11 48 28 25 52 120
2022/20231.056 101 254 44 77 61 175 144 50 93 7 24 26
2023/2024412 16 32 64 10 21 91 24 95 9 19 13 18
2024/20252.533 86 275 155 380 804 428 34 77 57 56 104 77
2025/20261.455 279 362 175 290 306 43 0 0 0 0 0 0
Totale 8.522